Treatment of advanced Hodgkin's disease with chemotherapy - Comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada Clinical Trials Group

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1638-1645

  Connors, Joseph M ^a   Klimo, Paul ^a   Adams, Grenfell ^a   Burns, Bruce F ^a   Cooper, Ian ^a   Meyer, Ralph M ^a   O'Reilly, Susan E ^a   Pater, Joseph ^a   Quirt, Ian ^a   Sadura, Anna ^a   Shustik, Chaim ^a   Skillings, Jamey ^a   Sutcliffe, Simon ^a   Verma, Shailendra ^a   Yoshida, Sam ^a   Zee, Benny ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 8244252294     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1638     Document Type: Article

References (24)

1. DeVita VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895, 1970
2. Longo D, Young RC, Wesley M, et al: Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 4:1295-1306, 1986
3. Bakemeier RF, Anderson JR, Costello W, et al: BCVPP chemotherapy for advanced Hodgkin's disease: Evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Ann Intern Med 101:447-456, 1984
4. Young RC, Chabner BA, Canellos GP, et al: Maintenance chemotherapy for advanced Hodgkin's disease in remission. Lancet 1:1339-1343, 1973
5. Bonadonna G: Chemotherapy strategies to improve the control for Hodgkin's disease: The Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 42:4309-4320, 1982
6. Santoro A, Bonfante V, Bonadonna G: Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. Ann Intern Med 96:139-143, 1982
7. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
8. Glick J, Tsiatis A, Chen M, et al: Improved survival with MOPP-ABVD compared to BCVPP ± radiotherapy (RT) for advanced Hodgkin's disease: 6-year ECOG results. Blood 76:350a, 1990 (suppl; abstr)
9. Bonadonna G, Valagussa P, Santoro A: Alternating non-cross-resistant combination chemotherapy or MOPP in stage FV Hodgkin's disease. Ann Intern Med 104:739-746, 1986
10. Hancock BW, Hudson GV, Hudson BV, et al: LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: Results of a British National Lymphoma Investigation Trial. J Clin Oncol 10:1252-1258, 1992
11. Glick J, Tsiatis A, Schilsky R, et al: A randomized phase III trial of MOPP/ABV hybrid vs sequential MOPP-ABVD in advanced Hodgkin's disease: Preliminary results of the intergroup trial. ECOG, CALGB, and SWOG. Proc Am Soc Clin Oncol 10:271, 1991 (abstr)
12. Connors JM: Is cyclical chemotherapy better than standard four drug chemotherapy for Hodgkin's Disease? Yes. Important Adv Oncol 189-195, 1993
13. Klimo P, Connors JM: MOPP/ABV hybrid program: Combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. J Clin Oncol 3:1174-1182, 1985
14. Connors JM, Klimo P: MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease. Semin Hematol 24:35-40, 1987 (suppl 1)
15. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860-1861, 1971
16. Agresti A: Pearson chi-square statistic, in Categorical Data Analysis. New York, NY, Wiley, 1990, pp 47-48
17. Agresti A: Fisher's exact test, in Categorical Data Analysis. New York, NY, Wiley, 1990, pp 59-66
18. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
21. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
22. Gail M, Simon R: Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 41:361-372, 1985
23. Conover W: Mann-Whitney-Wilcoxon test, in Practical Non-parametric Statistics (ed 2). New York, NY, Wiley, 1980, pp 213-228
24. Viviani S, Bonadonna G, Santoro A, et al: Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results. J Clin Oncol 14:1421-1430, 1996